JEAN JACQUES BIENAIME
CIK 1221590 · Chief Executive Officer · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$33.83M
Companies
6
Total Filings
462
Lifetime Open-Market Net
-$240.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KROS | Director | 18,592 | $10.07 | $187.2K | $65.5K | 8 | 2026-07-17 |
| IMNM | Director | 38,915 | $23.22 | $903.6K | $437.4K | 12 | 2026-06-12 |
| INCY | Director | 24,424 | $129.93 | $3.17M | $320.5K | 45 | 2026-06-10 |
| ASND | Director | 600 | $254.44 | $152.7K | $206.7K | 2 | 2026-06-01 |
| BMRN | Director | 473,892 | $62.07 | $29.41M | -$241.37M | 336 | 2024-05-21 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 1,706 | — | — | $3.9K | 4 | 2014-03-10 |
Recent Filings · Page 3 of 47
462 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-19 | IMNM | Buy (P) | +7,000 | $97.6K | EDGAR |
| 2024-06-18 | IMNM | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | INCY | Grant (A) | +2,830 | $0 | EDGAR |
| 2024-06-05 | KROS | Grant (A) | — | $0 | EDGAR |
| 2024-05-31 | BMRN | Notice (144) | −31,000 | -$2.31M | EDGAR |
| 2024-05-30 | BMRN | Notice (144) | −20,000 | -$1.50M | EDGAR |
| 2024-05-22 | IMNM | Buy (P) | +2,000 | $27.1K | EDGAR |
| 2024-05-21 | BMRN | Tax (F) | −1,202 | -$92.6K | EDGAR |
| 2024-05-13 | BMRN | Mixed | — | -$731.2K | EDGAR |
| 2024-05-10 | BMRN | Notice (144) | −20,000 | -$1.62M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.